FDA grants accelerated approval to dostarlimab for rectal cancerOct 19Regulatory decisiondostarlimab-gxlyGlaxoSmithKline
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
GSK's IPF drug GSK3915393 fails Phase 2 on futility; expanded access opens for velzatinib in GISTSep 18Weekly roundup, 3 itemsGlaxoSmithKlineGSK3915393
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant